Significant Morbidity and Mortality Among Hospitalized End-Stage Liver Disease Patients in Medicare.

ABSTRACT:

Context

For end-stage liver disease (ESLD) patients, care focuses on managing the life-threatening complications of portal hypertension, causing high resource utilization.

Objectives

To describe the end-of-life trajectory of hospitalized ESLD patients in Medicare.

Methods

Using a 5% random sample of Medicare fee-for-service beneficiaries, we performed a retrospective cohort study, identifying hospitalized ESLD and heart failure (HF) patients (2007-2011). Index hospitalization end points included mortality, discharge to hospice, and length of stay. Postdischarge end points included all-cause mortality, rehospitalization, hospice enrollment, and days alive and out of hospital (DAOH). Follow-up was at one and three years after index hospitalization discharge. A reference

SUBMITTER: Brown CL 

PROVIDER: S-EPMC5144155 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature